JP2022535743A5 - - Google Patents
Info
- Publication number
- JP2022535743A5 JP2022535743A5 JP2021570361A JP2021570361A JP2022535743A5 JP 2022535743 A5 JP2022535743 A5 JP 2022535743A5 JP 2021570361 A JP2021570361 A JP 2021570361A JP 2021570361 A JP2021570361 A JP 2021570361A JP 2022535743 A5 JP2022535743 A5 JP 2022535743A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- independently selected
- group
- substituted
- ring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962854288P | 2019-05-29 | 2019-05-29 | |
| US62/854,288 | 2019-05-29 | ||
| PCT/US2020/035249 WO2020243519A1 (en) | 2019-05-29 | 2020-05-29 | Compounds and compositions for treating conditions associated with sting activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022535743A JP2022535743A (ja) | 2022-08-10 |
| JP2022535743A5 true JP2022535743A5 (enExample) | 2023-06-01 |
Family
ID=71787083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021570361A Pending JP2022535743A (ja) | 2019-05-29 | 2020-05-29 | Ｓｔｉｎｇ活性に関連する状態を治療するための化合物および組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220227760A1 (enExample) |
| EP (1) | EP3976584A1 (enExample) |
| JP (1) | JP2022535743A (enExample) |
| MA (1) | MA56047A (enExample) |
| WO (1) | WO2020243519A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120004785A (zh) | 2018-07-03 | 2025-05-16 | 诺华制药股份有限公司 | 用于治疗与sting活性有关的疾病的化合物和组合物 |
| TW202200136A (zh) | 2020-04-10 | 2022-01-01 | 日商小野藥品工業股份有限公司 | 癌治療方法 |
| JP2023554393A (ja) * | 2020-12-16 | 2023-12-27 | アイエフエム デュー インコーポレイテッド | Ｓｔｉｎｇ活性に関連する状態を治療するための化合物および組成物 |
| US20240051970A1 (en) * | 2020-12-16 | 2024-02-15 | Ifm Due, Inc. | Compounds and compositions for treating conditions associated with sting activity |
| EP4267129A1 (en) | 2020-12-22 | 2023-11-01 | IFM Due, Inc. | Methods of treating cancer |
| EP4267128A1 (en) | 2020-12-22 | 2023-11-01 | IFM Due, Inc. | Methods of treating cancer |
| JP2024500874A (ja) | 2020-12-22 | 2024-01-10 | アイエフエム デュー インコーポレイテッド | がんを処置する方法 |
| US20240060982A1 (en) * | 2020-12-22 | 2024-02-22 | Ifm Due, Inc. | Methods of treating cancer |
| EP4274824A1 (en) | 2021-01-08 | 2023-11-15 | IFM Due, Inc. | Heterobicyclic compounds having an urea or analogue and their compositions for treating conditions associated with sting activity |
| IL310724A (en) | 2021-08-10 | 2024-04-01 | Ifm Due Inc | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH STING ACTIVITY |
| WO2024064358A1 (en) | 2022-09-23 | 2024-03-28 | Ifm Due, Inc. | Compounds and compositions for treating conditions associated with sting activity |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002022605A1 (en) * | 2000-09-15 | 2002-03-21 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
| US7927613B2 (en) | 2002-02-15 | 2011-04-19 | University Of South Florida | Pharmaceutical co-crystal compositions |
| UA95244C2 (ru) * | 2005-06-22 | 2011-07-25 | Плексикон, Инк. | Соединения и способ модулирования активности киназ, и показания для их применения |
| CN102812023A (zh) * | 2010-01-13 | 2012-12-05 | 韩国巴斯德研究所 | 抗感染吡啶并(1,2-a)嘧啶类 |
| US8497285B2 (en) | 2010-12-03 | 2013-07-30 | The Trustees Of The University Of Pennsylvania | Therapy of autoimmune colitis using a TIP60 inhibitor |
| JP6121658B2 (ja) * | 2011-06-29 | 2017-04-26 | 大塚製薬株式会社 | 治療用化合物、及び関連する使用の方法 |
| US9260426B2 (en) * | 2012-12-14 | 2016-02-16 | Arrien Pharmaceuticals Llc | Substituted 1H-pyrrolo [2, 3-b] pyridine and 1H-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (SIK2) inhibitors |
| PE20160080A1 (es) | 2013-05-18 | 2016-02-21 | Aduro Biotech Inc | Composiciones y metodos para activar la senalizacion que depende del estimulador del gen de interferon |
| CA2927009C (en) | 2013-10-21 | 2019-04-23 | Drexel University | Use of sting agonists to treat chronic hepatitis b virus infection |
| WO2015131005A1 (en) * | 2014-02-28 | 2015-09-03 | The Regents Of The University Of Michigan | 9h-pyrimido[4,5-b]indoles and related analogs as bet bromodomain inhibitors |
| EP3632915A1 (en) * | 2014-11-27 | 2020-04-08 | Genentech, Inc. | 4,5,6,7-tetrahydro-1 h-pyrazolo[4,3-c]pyridin-3-amine compounds as cbp and/or ep300 inhibitors |
| JP7636322B2 (ja) * | 2018-11-15 | 2025-02-26 | アンスティテュ・ギュスターヴ・ルシー | 癌を処置するためのマドラシン誘導体化合物、組成物およびこれらの使用 |
| JP2022507697A (ja) * | 2018-11-19 | 2022-01-18 | アイエフエム デュー インコーポレイテッド | Ｓｔｉｎｇ活性に関連する状態を治療するための化合物および組成物 |
-
2020
- 2020-05-29 WO PCT/US2020/035249 patent/WO2020243519A1/en not_active Ceased
- 2020-05-29 MA MA056047A patent/MA56047A/fr unknown
- 2020-05-29 US US17/610,570 patent/US20220227760A1/en not_active Abandoned
- 2020-05-29 JP JP2021570361A patent/JP2022535743A/ja active Pending
- 2020-05-29 EP EP20746384.5A patent/EP3976584A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022535743A5 (enExample) | ||
| JP2023509422A5 (enExample) | ||
| WO2023072197A1 (en) | Piperidinyl indole derivatives, preparation methods and medicinal uses thereof | |
| KR102345381B1 (ko) | 키나제 억제제로서 유용한 카르바졸 카르복스아미드 화합물 | |
| JP6353529B2 (ja) | 置換されたテトラヒドロカルバゾールおよびカルバゾールカルボキサミド化合物 | |
| AU2003258576B2 (en) | Pyrrolidinedione substituted piperidine-phthalazones as PDE4 inhibitors | |
| JP4890723B2 (ja) | ＴＮＦαインヒビターとして有用なクマリン誘導体 | |
| US20080227789A1 (en) | Diaminothiazoles useful as axl inhibitors | |
| US20040038939A1 (en) | Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity | |
| AR038864A1 (es) | Inhibidores pirimidina y piridina biciclicos de la p38 quinasa | |
| PE20011166A1 (es) | Piridinas, pirimidinas, purinonas, pirrolopirimidinonas y pirrolopiridinonas como antagonistas del factor liberador de corticotropina | |
| EP1541574A1 (en) | Triazaspiro 5.5 undecane derivatives and drugs comprisi ng the same as the active ingredient | |
| CZ113297A3 (cs) | Derivát karboxylové kyseliny | |
| AR045260A1 (es) | Compuestos que contienen imidazo-oxima sustituidos | |
| RU2008130884A (ru) | Гетероциклические ингибиторы янус-киназы 3 | |
| RU2008109185A (ru) | Получение и применение тетрагидропиролло[3, 2-с]пиридин-4-оновых производных для лечения ожирения, психиатрических и неврологических расстройств | |
| JP2011500801A (ja) | Ａｘｌ阻害剤として有用な多環アリール置換トリアゾール及び多環ヘテロアリール置換トリアゾール | |
| AU2013277476A1 (en) | 1,2,4-triazine-6-carboxamide kinase inhibitors | |
| RU2003134371A (ru) | Пиразоло [1, 5-а] пиридины и содержащие их лекарственные средства | |
| TW202003487A (zh) | 經取代的２，２＇—聯嘧啶基化合物、其類似物及其使用方法 | |
| JP2024502473A5 (enExample) | ||
| RU2009128968A (ru) | Производные изосорбидмононитрата для лечения повышенной внутриглазной гипертензии | |
| AR055431A1 (es) | Derivados del acido 4-amino-tieno[3,2-c]piridina-7-carboxilico | |
| JP2023519363A5 (enExample) | ||
| CA3157778A1 (en) | Substituted isoindolonyl 2,2'-bipyrimidinyl compounds, analogues thereof, and methods using same |